Amarin

Two Years Less Exclusivity Is the Least of Amarin's Issues
Motley Fool
Tue, 02/25/14 - 11:15 am
Amarin
exclusivity
Vascepa
Amarin Loses Bid for Vascepa 5-Year Market Exclusivity
TheStreet.com
Mon, 02/24/14 - 08:51 am
Amarin
Vascepa
Amarin Corporation Plc's Rocky Road
Motley Fool
Sat, 02/15/14 - 11:23 am
Amarin
Amarin Tumbles after DMEP Decision
Yahoo/Zacks.com
Wed, 01/22/14 - 05:23 pm
Amarin
DMEP
Vascepa
Amarin says FDA won't reinstate special protocol assessment for ANCHOR study
First Word Pharma
Tue, 01/21/14 - 08:12 am
FDA
Amarin
Vascepa
Amarin Out, Intercept Pharma In at JPMorgan Healthcare Confab
TheStreet.com
Mon, 01/13/14 - 08:40 am
Amarin
Intercept Pharma
JPMHC 2014
OCA
Vascepa
Small Cap BioPharmas With Near-Term Catalysts
Seeking Alpha
Fri, 01/3/14 - 12:00 pm
Amarin
Venaxis
Progenics
Celldex Therapeutics
Relistor
Vascepa
The Best- And Worst-Performing Biotech Stocks Of 2013
Forbes
Thu, 01/2/14 - 10:45 am
biotech
Puma Biotechnology
Acadia
Isis Pharmaceuticals
Infinity Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Aveo Oncology
4 Biggest Biotech Disasters Of 2013
Forbes
Wed, 01/1/14 - 11:41 am
Amarin
Vascepa
Ariad Pharmaceuticals
Iclusig
Celsion
ThermoDox
IPI-145
Infinity Pharmaceuticals
Amarin: 3 Things Shareholders Should Demand In 2014
Seeking Alpha
Mon, 12/30/13 - 11:12 am
Amarin
Vascepa
Is Amarin's Luck About to Change?
Motley Fool
Tue, 12/24/13 - 09:48 am
Amarin
Vascepa
Will FDA Widen Use For The Vasecpa Fish Oil Pill, After All?
Pharmalot
Mon, 12/23/13 - 10:26 am
FDA
Vascepa
Amarin
No News Is Good News for Amarin
Motley Fool
Sun, 12/22/13 - 12:32 pm
Amarin
Amarin's Anchor Gamble Sends Stock Up 20% On 'No News' News
Seeking Alpha
Fri, 12/20/13 - 11:52 am
Amarin
Vascepa
FDA
Amarin Says U.S. Ruling on Fish Oil Pill Delayed on Trial
Bloomberg
Fri, 12/20/13 - 08:49 am
Vascepa
FDA
Amarin
Amarin: Summarizing The Variables Involved In The Upcoming PDUFA
Seeking Alpha
Wed, 12/18/13 - 09:44 am
Amarin
FDA
Vascepa
The Worst Biotech CEO of 2013 Is...
TheStreet.com
Tue, 12/17/13 - 08:48 am
biotech
Vical
Ariad Pharma
Aveo Oncology
Dendreon
Amarin
Amarin CEO to Step Down; Replacement Named
Motley Fool
Mon, 12/16/13 - 02:18 pm
Amarin
Pharma CEOs
Joseph Zakrzewski
Will Amarin And Arena See Better Sales In 2014?
Seeking Alpha
Thu, 12/5/13 - 06:59 pm
Amarin
Arena Pharmaceuticals
Vascepa
Belviq
3 Biggest FDA Decisions of 2013
Motley Fool
Wed, 12/4/13 - 08:18 am
FDA
Sarepta Therapeutics
drisapersen
Iclusig
Ariad Pharmaceuticals
Vascepa
Amarin

Pages